Table 2.
All sessions | Placebo Arm | Acyclovir Arm | |
---|---|---|---|
Number of days with genital lesions/all days (%) | 259 / 2694 (10) | 197 / 1360 (14) | 62 / 1334 (5)** |
Number of genital lesion episodes, N (%) | 35 (100) | 26 (74) | 9 (26)* |
Duration of genital lesion episodes (days), median (range) | 6 (1–19) | 7 (2–19) | 4 (1–17) |
p < 0.05
p < 0.001